Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Filtros aplicados
Base de dados
Intervalo de ano de publicação
1.
Копенгаген; Всемирная организация здравоохранения. Европейское региональное бюро; 2023. (WHO/EURO:2023-8315-40487-71316).
em Russo | WHO IRIS | ID: who-373971

RESUMO

Устранив основные причины дефицита лекарств, политики получают возможность решить проблему непосредственной нехватки; проблемы, связанные с цепочкой поставок и спроса на противомикробные препараты, а также множество косвенных и возникающих проблем. Наличие постоянного доступа к широкому спектру противомикробных препаратов имеет решающее значение для рационального использования противомикробных препаратов, позволяя врачам использовать правильные лекарства для целенаправленного лечения. Это включает в себя предупреждение человеческих, социальных и экономических издержек, связанных с УПП, а также помощь в предотвращении возникновения и распространения УПП


Assuntos
Resistência a Múltiplos Medicamentos , Infecções , Medicina , Vacinas , Bactérias
2.
Copenhagen; World Health Organization Regional Office for Europe; 2023. (WHO/EURO:2023-8315-48087-71313).
em Inglês | WHO IRIS | ID: who-373969

RESUMO

By addressing the primary causes of medicines shortages, policy-makers have an opportunity to solve the immediate shortage as well as the supply and demand chain-related challenges of antimicrobials, and a plethora of indirect and downstream issues. Having continuous access to a wide range of antimicrobials is crucial for antimicrobial stewardship, allowing clinicians to use the right medicines for targeted treatment. This includes averting the human, social and economic costs related to AMR and helping to prevent the emergence and spread of AMR.


Assuntos
Medicina , Vacinas , Bactérias , Infecções , Resistência a Múltiplos Medicamentos
4.
Копенгаген; Всемирная организация здравоохранения. Европейское региональное бюро; 2020. (WHO/EURO:2020-5542-45307-64848).
em Russo | WHO IRIS | ID: who-356851

RESUMO

Международные сети по лабораторному надзору, обеспечению готовности и ответным действиям представляют собой важный механизм усиления лабораторных служб, поскольку они могут служить как платформой для обмена информацией и экспертными знаниями, так и системой направления клинических образцов на первичное и подтверждающее тестирование. Из числа приоритетных стран Программы ВОЗ по чрезвычайным ситуациям в области здравоохранения в Европейском регионе остается ряд стран, которые не участвуют в деятельности международных сетей по обеспечению лабораторной готовности и реагирования в связи с особо опасными патогенами (ООП), что рассматривается как серьезный пробел. Для его восполнения Европейское региональное бюро ВОЗ сформировало Европейскую региональную лабораторную специальную группу по особо опасным патогенам (Лабораторную специальную группу). Настоящее совещание явилось первой официальной встречей членов и партнеров Лабораторной специальной группы. Совещание дало возможность представить информацию о глобальной и региональной ситуации с распространением вируса, вызывающего COVID-19, в том числе, о готовности лабораторных служб.


Assuntos
Laboratórios , Serviços de Laboratório Clínico , Bactérias , Vírus , Surtos de Doenças , COVID-19 , Fortalecimento Institucional , Europa (Continente)
5.
Copenhagen; World Health Organization. Regional Office for Europe; 2020. (WHO/EURO:2020-5542-45307-64847).
em Inglês | WHO IRIS | ID: who-356850

RESUMO

International networks for laboratory surveillance, preparedness and response are an important tool for laboratory strengthening, because they can serve both as a platform for sharing information and expertise, and as a system for the referral of diagnostic specimens for primary and confirmatory testing. Among the European Region priority countries of the WHO Health Emergencies Programme a number do not participate in international laboratory preparedness and response networks for High Threat Pathogens (HTPs), which represents a key gap. To address this gap, the WHO Regional Office for Europe is establishing the European Regional Laboratory Task Force for High Threat Pathogens (Lab Task Force). This was the first official meeting of the Lab Task Force’s members and partners and the opportunity to provide information on COVID-19 virus globally and in the Region, including laboratory readiness, was taken.


Assuntos
Laboratórios , Serviços de Laboratório Clínico , Bactérias , Vírus , Surtos de Doenças , COVID-19 , Fortalecimento Institucional , Europa (Continente)
8.
(East. Mediterr. health j).
em Árabe | WHO IRIS | ID: who-118970

RESUMO

Sharp dental bridges are still used among dental treatments in certain countries including Iraq. This study was conducted to indicate the differences in microbial and immunological effects on patients using sharp versus cast dental bridges


Assuntos
Imunoglobulinas , Saliva , Bactérias , Materiais Dentários , Dentaduras
9.
(East. Mediterr. health j).
em Inglês | WHO IRIS | ID: who-117750

RESUMO

Over a 14-month period, 77 children with a presumptive diagnosis of acute bacterial meningitis were investigated. The incidence of acute bacterial meningitis was 0.8%, with a case fatality rate of 13.0%. Children pound 1 year of age were more affected [64.9%]. The total male to female ratio was 1.2:1. Gram stain detected more cases [85.7%] than culture [66.2%]. A total of 48 isolates were identified by culture and their antibiotic sensitivity was determined. Haemophilus influenzae [33.8%] was the predominant organism identified, followed by Streptococcus pneumoniae [26.0%], Klebsiella spp. [6.5%] and Neisseria meningitidis [2.6%]. Many of the bacterial isolates were sensitive to gentamicin, cefotaxime and ceftriaxone and least sensitive to tetracycline and ampicillin


Assuntos
Meningites Bacterianas , Bactérias , Testes de Sensibilidade Microbiana , Meios de Cultura , Doença Aguda , Criança
10.
(East. Mediterr. health j).
em Inglês | WHO IRIS | ID: who-119395

RESUMO

Microbial infections were observed in 30% [155/519] of all patients consecutively admitted in 1993 to the adult intensive care unit in the Jordan University Hospital in Amman. Gram-negative bacteria were involved in 110 [49%], Gram-positive bacteria in 69 [31%], mixed bacteria species in 25 [11%] and Candida spp. in 19 [9%] of all 223 infection episodes. Five species were isolated most frequently: Staphylococcus aureus [40], Acinetobacter spp. [28] Pseudomonas spp. [22], Enterobacter spp. [20] and Klebsiella spp. [17]. Resistance to most commonly available antibiotics was moderate to very high among Gram-positive and Gram-negative isolates. Almost all Gram-negative bacteria were sensitive to imipenem and ciprofloxacin


Assuntos
Antibacterianos , Resistência Microbiana a Medicamentos , Cuidados Críticos , Bactérias , Infecções
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...